ASCO: ASCO 2024 commentary: data and therapeutic standouts
While the science at ASCO continued to push the boundaries for cancer care, much of the conversation in the hallways revolved around the ever-increasing challenges on translating trial successes into clinical practice.The post ASCO 2024 commentary: data and therapeutic standouts appeared first on PharmaLive.
Read full article »
ASCO is a Virginia-based nonprofit organization that represents and promotes physicians and oncology professionals caring for people with cancer.
Read more